|Bid||73.41 x 900|
|Ask||73.68 x 1800|
|Day's Range||71.30 - 74.35|
|52 Week Range||64.41 - 104.83|
|Beta (5Y Monthly)||0.53|
|PE Ratio (TTM)||11.26|
|Earnings Date||Feb 06, 2024 - Feb 12, 2024|
|Forward Dividend & Yield||2.66 (3.62%)|
|Ex-Dividend Date||Jan 19, 2024|
|1y Target Est||80.77|
Subscribe to Yahoo Finance Plus to view Fair Value for CVS
Shares of CVS Health (NYSE: CVS) rallied out of the gate on Wednesday morning, adding as much as 4.7%. The catalyst that sent the healthcare giant higher was bullish takes from a trio of Wall Street analysts. In the wake of the company's investor day on Tuesday, analysts are more bullish on the future prospects and the growing opportunity for CVS.
Apple’s back above $3 trillion, Elon Musk’s AI start-up is raising $1 billion, bank CEOs emphasize economic risks of new capital proposals, and other news to start your day.
The way pharmacies in the United States make money is … kind of a mystery.